Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
N Engl J Med. 2021 Sep 09; 385(11):961-964.NEJM

Authors+Show Affiliations

From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34289273

Citation

Rapeport, Garth, et al. "SARS-CoV-2 Human Challenge Studies - Establishing the Model During an Evolving Pandemic." The New England Journal of Medicine, vol. 385, no. 11, 2021, pp. 961-964.
Rapeport G, Smith E, Gilbert A, et al. SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic. N Engl J Med. 2021;385(11):961-964.
Rapeport, G., Smith, E., Gilbert, A., Catchpole, A., McShane, H., & Chiu, C. (2021). SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic. The New England Journal of Medicine, 385(11), 961-964. https://doi.org/10.1056/NEJMp2106970
Rapeport G, et al. SARS-CoV-2 Human Challenge Studies - Establishing the Model During an Evolving Pandemic. N Engl J Med. 2021 Sep 9;385(11):961-964. PubMed PMID: 34289273.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic. AU - Rapeport,Garth, AU - Smith,Emma, AU - Gilbert,Anthony, AU - Catchpole,Andrew, AU - McShane,Helen, AU - Chiu,Christopher, Y1 - 2021/07/21/ PY - 2021/7/22/pubmed PY - 2021/9/14/medline PY - 2021/7/21/entrez SP - 961 EP - 964 JF - The New England journal of medicine JO - N Engl J Med VL - 385 IS - 11 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/34289273/SARS-CoV-2_Human_Challenge_Studies_-_Establishing_the_Model_during_an_Evolving_Pandemic. L2 - https://www.nejm.org/doi/10.1056/NEJMp2106970?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -